- Published at
- by investing.com
positive
positive
Mithra postpones its annual general meeting By Investing.com
Mithra postpones its annual general meeting
News for Mithra Pharmaceuticals SA (MITRA.BR)
- Published at
- by marketscreener.com
positivepositiveMithra postpones its annual general meeting
Liege, Belgium, 28 May 2024 – 15:00 CEST – Mithra , a company dedicated to women’s health, today announces that in the context of the monetization process and the uncertainties related thereto,...- Published at
- by marketscreener.com
positivepositiveRichter Gedeon Vegyeszeti Gyár Nyilvánosan Muködo Rt : Extraordinary Information
Richter has submitted an offer and entered into negotiations to acquire certain assets from Mithra Pharmaceuticals in Belgium Budapest, 3...- Published at
- by globenewswire.com
positivepositiveMithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process
Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent...- Published at
- by marketscreener.com
positivepositiveMithra updates on offers received in the context of its monetization process and on its Annual Report 2023
Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure full...- Published at
- by benzinga.com
positivepositive- Published at
- by globenewswire.com
positivepositiveMithra reports full year 2023 financial results
Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from the 2022 result of EUR 67.0 million which was positively...- Published at
- by marketscreener.com
positivepositiveMithra announces changes to its executive management -March 05, 2024 at 01:02 am EST
Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra , a company dedicated to women’s health, today announces the termination of the...- Published at
- by marketscreener.com
positivepositiveMithra initiates monetization process, receives bridge loan from existing lenders
Mithra initiates monetization process, receives bridge loan from existing lenders Mithra appoints advisors and initiates a process to monetize its assets or execute a sale of its businessMithra...- Published at
- by gurufocus.com
positivepositiveHalf Year 2023 Mithra Pharmaceuticals SA Earnings Call Transcript
Sep 26, 2023 / 12:00PM GMTOperator Hello, and welcome to the Mithra Half Year Results 2023. My name is Jess, and I'll be your coordinator for today's event. Ple- Published at
- by marketscreener.com
positivepositiveMithra sells shares in Mayne Pharma
Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma for EUR ~12.8 millionAs the Mayne Pharma shares were pledged to the secured lenders of...- Published at
- by globenewswire.com
positivepositiveMithra sells shares in Mayne Pharma
Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma for EUR ~12.8 millionAs the Mayne Pharma shares...- Published at
- by marketscreener.com
positivepositiveMithra Pharmaceuticals S A : and Lotus announce approval of ALYSSA®, an innovative oral contraceptive, in both Taiwan and Hong Kong
21 September 2022, 7:30 CEST - Taipei City, Taiwan and Liege, Belgium - Lotus Pharmaceutical Co., Ltd. and Mithra Pharmaceuticals, SA today are pleased to announce that Estelle®, the... | September 21, 2022